GX 623 (Ziagen 300 mg)
Generic Name: abacavir
Pill imprint GX 623 has been identified as Ziagen 300 mg.
Ziagen is used in the treatment of nonoccupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Ziagen 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for GX 623 (Ziagen 300 mg)
- Generic Name:
- 300 mg
- 18.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide colloidal
sodium starch glycolate type A potato
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54569-4883||A S Medication Solutions LLC (repackager)|
|54868-4522||Physicians Total Care Inc (repackager)|
|35356-0075||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Ziagen (abacavir)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...